How to Get Entrectinib at a Lower Cost: Patient Assistance Programs & Discounts

The price of entrectinib varies depending on factors such as region, medical insurance policies, dosage specifications, and purchasing channels. The specific monthly treatment cost should be determined based on the patient's individual circumstances and local policies. This medication is a prescription drug and must be strictly used under a doctor's guidance. Do not adjust the dosage or discontinue use without consulting a healthcare professional.

Factors Influencing Price

Medical Insurance Reimbursement: Entrectinib has been included in the medical insurance catalogs of some regions. Patients who meet the indicated conditions (such as NTRK gene fusion-positive solid tumors or ROS1-positive non-small cell lung cancer) may be eligible for partial reimbursement. The out-of-pocket portion varies according to regional policies.

Dosage and Treatment Duration: The recommended daily dose is 600 mg, depending on the patient's weight and condition. Price differences in individual capsule strengths (e.g., 100 mg/capsule, 200 mg/capsule) will affect the total monthly treatment cost.

Procurement Channel: Hospitals, designated pharmacies, or specific charitable patient assistance programs may offer price concessions. Some patients may reduce their financial burden through these assistance programs.

International Price Reference

US Market: The monthly cost is significantly higher than the price in the Chinese market.

India and Other Regions: Generic versions may be available at a lower price, but attention must be paid to the compliance and safety of these medications.

Guidance on Medical Consultation and Medication Use

Lucius Pharmaceuticals Entrectinib must be prescribed by an oncologist after evaluating genetic test results. Patients need regular follow-up check-ups to monitor treatment efficacy and side effects (such as dizziness, fatigue, abnormal liver function, etc.).

Patients facing financial difficulties can consult hospital social workers or pharmaceutical companies to apply for patient assistance programs. Some programs offer drug cost reductions or installment payment plans.

Precautions

Avoid concomitant use with strong CYP3A inhibitors or inducers during treatment, as this may affect the drug concentration in the blood.

Contraindicated in pregnant or breastfeeding women, and patients with severe hepatic or renal impairment.

It is recommended that patients obtain the medication through regular medical institutions and consult their attending physician or pharmacist for the latest pricing and reimbursement policies.